Showing results (61-70 of 128) with videos related to
Sort By:
Pageof 13
JCO Precision Oncology|July 12, 2021
Differential Impact of ALK Mutations in NeuroblastomaTara O'Donohue, Nitya Gulati, Audrey Mauguen, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 22, 2019
11C-Choline PET/CT in Recurrent Prostate Cancer: Retrospective Analysis in a Large U.S. Patient SeriesLaure Michaud, Karim A Touijer, Audrey Mauguen, et al.Research Square|June 29, 2026
ATG Exposure in T Replete Transplant for Hematological Malignancies: Real World Analysis from BMT CTN 1202Jaap Jan Boelens, Madhavi Lakkaraja, Audrey Mauguen, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 25, 2014
Cost effectiveness of modified fractionation radiotherapy versus conventional radiotherapy for unresected non-small-cell lung cancer patientsBram L T Ramaekers, Manuela A Joore, Béranger Lueza, et al.Plos One|October 2, 2010
Portrait of ependymoma recurrence in children: biomarkers of tumor progression identified by dual-color microarray-based gene expression analysisMatthieu Peyre, Frédéric Commo, Carmela Dantas-Barbosa, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 16, 2011
Prognostic impact of morphologic and phenotypic features of childhood ALK-positive anaplastic large-cell lymphoma: results of the ALCL99 studyLaurence Lamant, Keith McCarthy, Emanuele d'Amore, et al.Pediatric Hematology and Oncology|May 7, 2025
Reducing empiric antibiotic administration in pediatric oncology patients with non-neutropenic fever: a single-center quality improvement initiativeAlexandra Satty, Jessica Stiefel, Audrey Mauguen, et al.Radiology|July 19, 2022
18F-DCFPyL PET/CT for Initially Diagnosed and Biochemically Recurrent Prostate Cancer: Prospective Trial with Pathologic ConfirmationGary A Ulaner, Beth Thomsen, Jeffrey Bassett, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 14, 2020
PARP1: A Potential Molecular Marker to Identify Cancer During Colposcopy ProceduresPaula Demétrio de Souza França, Navjot Guru, Abigail R Kostolansky, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 9, 2025
Detection of HER2-Low Lesions Using HER2-Targeted PET Imaging in Patients with Metastatic Breast Cancer: A Paired HER2 PET and Tumor Biopsy AnalysisRandy Yeh, Fresia Pareja, Parnian Shobeiri, et al.Pageof 13